Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Disruptions to the hearing health sector

Technological innovation and changes to regulation are disrupting the hearing health sector, with implications for data privacy, product safety and accessibility, and provide challenges and opportunities for equitable hearing health.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. WHO. https://go.nature.com/3TxrVqv (2021).

  2. Nieman, C. L. et al. J. Aging Health 28, 68–94 (2016).

    Article  Google Scholar 

  3. Lee, L. https://go.nature.com/3N3rGkU (2019).

  4. Hunn, N. http://bit.ly/hearables2025 (2020).

  5. FDA. 87 FR 50698; https://go.nature.com/3z6C7yk (2022).

  6. Zuboff, S. The Age of Surveillance Capitalism: the Fight for a Human Future at the New Frontier of Power (Public Affairs, 2019).

  7. Prainsack, B. & Forgó, N. Nat. Med. https://doi.org/10.1038/s41591-022-01955-4 (2022).

  8. Coiera, E. et al. J. Am. Med. Inform. Assoc. 28, 1815–1825 (2021).

    Article  Google Scholar 

  9. Crum, P. https://go.nature.com/3spEcBK (2019).

  10. Pontoppidan, N. H. et al. US Patent 20140369537A1; https://go.nature.com/3SqFKpn (2014).

  11. Ng, S. L. et al. Int. J. Audiol. 58, 576–586 (2019).

    Article  Google Scholar 

  12. Sininger, Y. et al. Audiology Today 15, 14–17 (2003).

    Google Scholar 

  13. Liang, B. A. Semin. Hear. 27, 48–56 (2006).

    Article  Google Scholar 

  14. McMahon, C. M. et al. Public Health Res. Pract. 31, e3152128 (2021).

    Google Scholar 

  15. Dawes, P. et al. Int. J. Audiol. 52, 472–477 (2013).

    Article  Google Scholar 

  16. Coolen, J. et al. Can. J. Speech Lang. Pathol. Audiol. 36, 94–105 (2012).

    Google Scholar 

  17. Yong, M. et al. Bull. World Health Organ. 97, 699–710 (2019).

    Article  Google Scholar 

  18. Fournier, P. Hear. Rev. 24, 26–28 (2017).

    Google Scholar 

  19. ACCC. https://go.nature.com/3MZByMd (2017).

  20. Reed, N. S. et al. J. Am. Med. Assoc. 320, 1641–1642 (2018).

    Article  Google Scholar 

  21. Humes, L. E. et al. Am. J. Audiol. 26, 53–79 (2017).

    Article  Google Scholar 

  22. Martinez-Martin, N. et al. Lancet Digit. Health 3, e115–e123 (2020).

    Article  Google Scholar 

  23. Blustein, J. et al. JAMA Otolaryngol. Head Neck Surg. 146, 765–766 (2020).

    Article  Google Scholar 

  24. Shukla, A. et al. Am. J. Med. Qual. 34, 284–292 (2019).

    Article  Google Scholar 

  25. Arcaya, M. C. et al. Health Aff. (Millwood) 36, 992–998 (2017).

    Article  Google Scholar 

  26. Hsu, A. K. et al. Geriatr. Nurs. 40, 367–379 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

I.B., A.D., E.L., J.S.M. and W.L. conceived and developed the main ideas for this article. I.B. led the writing with substantial contributions from A.D., E.L. and M.C. All authors provided critical input, and approved the final version. M.N. provided a critical review from the perspective of a person with lived experience of hearing loss.

Corresponding author

Correspondence to Isabelle Boisvert.

Ethics declarations

Competing interests

I.B. is a collaborator on projects that receive funding from Cochlear, but maintains academic independence for all research initiatives. S.E.H. receives funding from the NIHR Blood and Transplant Research Unit (BTRU) in Precision Therapeutics, UKRI, National Technical Institute for the Deaf (NTID) COVID-19 Relief Fund, UK SPINE and declares personal fees from Cochlear, Astra Zeneca, CIS Oncolog, and Aparito outside the submitted work. M.C. receives funding from the National Institute for Health and Care Research (NIHR), UK Research and Innovation (UKRI), NIHR Birmingham Biomedical Research Centre, the NIHR Surgical Reconstruction and Microbiology Research Centre, NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Blood and Transplant Research Unit (BTRU) in Precision Therapeutics, UK SPINE, European Regional Development Fund – Demand Hub and Health Data Research UK at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB Pharma, Janssen, GSK and Gilead. M.C. has received personal fees from Astellas, Aparito, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside the submitted work; and a family member owns shares in GSK. The other authors declare having no relevant competing interests. The views expressed in this article are those of the authors and not necessarily those of their employing institutions.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boisvert, I., Dunn, A.G., Lundmark, E. et al. Disruptions to the hearing health sector. Nat Med 29, 19–21 (2023). https://doi.org/10.1038/s41591-022-02086-6

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41591-022-02086-6

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing